Navient Holdings completes reorganization, becomes successor issuer on Nasdaq

Christine Lagarde departs at a moment of peril

Wheels India reports 88% increase in net profit in Q2 FY27

Junshi Biosciences Announces the Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS207 in Combination with JS007 for the First-Line Treatment of Advanced Hepatocellular Carcinoma

Cognizant reports 4.8% CC growth in Q3; trims 2026 revenue guidance

MSCI Rejig: LIC, Meesho likely to enter India Standard Index; OFSS, Siemens Energy may be dropped